CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Complicationsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02699320
NCT02699320N/ACompleted
CompareCT.gov

Multi-center Clinical Research About Standard Diagnosis and Treatment of Neonate Severe Digestive System Malformation

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine·observational·Posted Mar 4, 2016·Updated Mar 4, 2016

In Brief

An observational study evaluating Complications for Short Bowel Syndrome and Complications. Completed, enrolled 33 participants across 1 site.

Detailed Summary

There are no reports involved the intestinal microbiota from Chinese infants with short bowel syndrome (SBS) under different clinical status. Alterations in the microbiota are closely correlated with the bile acids and short chain fatty acids metabolism as well as the intestinal immunity. A relatively comprehensive profile composed of microbial structure, microbial metabolism products and immune biomarkers in SBS infants may facilitate a better therapy strategy to complications occurred in SBS children.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsShort Bowel Syndrome, Complications
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 4, 2016
Enrollment StartJun 1, 2015
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.3 years ago

Interventions

Complicationsother

Not involved